Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 34 for “"Homologous Recombination Deficiency"”.
-
Selective targeting of homologous recombination deficiency
<p>Homologous recombination (HR) is a key DNA repair pathway essential for cell viability. Counter-intuitively, HR deficiency can trigger carcinogenesis. Understanding the mechanisms that allow the rampant proliferation of HR-deficient tumour cells is crucial for the development of improved …
-
Clinical Significance of Homologous Recombination Deficiency Score Testing In Endometrial Cancer
Objectives: Homologous recombination deficiency (HRD) score is related to chemotherapy response in breast and ovarian cancers. The role of HRD is unknown in endometrial cancer. We examined the relationship between HRD score and survival in a cohort of endometrial cancer patients and with tumor …
-
Structural variants of BRCA1/2 as a novel biomarker of homologous recombination deficiency
Homologous recombination deficiency (HRD) represents a cancer vulnerability that has been successfully exploited through the use of PARP inhibitors by synthetic lethality. In high grade serous ovarian cancer (HGSOC), PARP inhibitors, such as olaparib, have revolutionised treatments outcomes for …
-
Investigation into the relationship between PARPs in DNA repair and synthetic lethality with homologous recombination deficiency
… are in clinical use for their ability to kill homologous recombination deficient tumour cells, through a mechanism of synthetic lethality. Which subset of PARPs is necessary to inhibit to achieve maximum efficacy of these agents has not been assessed. </p> <p>I use genome editing to generate …
-
The predictive and prognostic significance of genomic instability and mutations in homologous recombination deficiency mechanism genes in ovarian cancer patients
Οι αναστολείς πολυ(ADP-ριβόζης) πολυμεράσης (PARP) ανέτρεψαν τη θεραπεία του καρκίνου των ωοθηκών, ιδιαίτερα στους ασθενείς με μεταλλάξεις BRCA1/2 και ανεπάρκεια ομόλογου ανασυνδυασμού (HRD), βελτιώνοντας σημαντικά την συνολική επιβίωση. Ωστόσο, εξακολουθούν οι ανησυχίες σχετικά με την …
-
The clinical actionability and evolution of mutational processes in metastatic cancer
… of a DNA repair pathway. Quantifying DNA repair deficiency can have clinical implications. Cancer chemotherapies which induce DNA damage are known to be more effective against cancers with deficient DNA repair. However, it is not yet known whether mutation signatures can serve as reliable …
-
UTILIZATION OF MOUSE TUBAL EPITHELIAL ORGANOIDS TO STUDY GENE COMBINATIONS OF HIGH GRADE SEROUS OVARIAN CARCINOMA AND CELL OF ORIGIN
… aside from TP53 and challenges related to the homologous recombination deficiency of HGSC, which can lead to significant genome loss. In my studies, I demonstrate that tubal epithelial (TE) organoids from the mouse uterine tube can be used in combinatorial screening to identify HGSC drivers and …
-
Three Variations of Precision Medicine: Gene-Aware Genome Editing, Ancestry-Aware Molecular Diagnosis, and Clone-Aware Treatment Planning
… patients exhibit higher genomic instability, homologous recombination deficiency, and aggressive molecular features such as chromothripsis. We next demonstrated that these molecular differences extend to many other cancer types. The prevalence of germline homologous recombination deficiency …
-
Human fallopian tube organoid models of high grade serous ovarian cancer initiation
… the effects of TP53 missense mutations and homologous recombination deficiency pathway members have also been designed. This research supports genetic perturbation of patient-derived normal organoids as a robust and promising avenue of research.
-
Analysis of Defects in Transcriptional Regulation Mechanisms in High-Grade Serous Ovarian Cancer and Their Correlation with Clinic-Pathological Features
… the correlation between defects in DNA repair Homologous Recombination and Pt sensitivity, we have started to develop an academic assay which exploits high-throughput DNA sequencing to evaluate Homologous Recombination Deficiency (HRD). Results obtained from three independent HGS-EOC cohorts …
-
Investigating the role of HORMAD1 in triple negative breast cancer
… experimental systems, HORMAD1 expression drives homologous recombination deficiency, PARP inhibitor and cisplatin sensitivity. To provide further insights into the role of HORMAD1 in TNBC, I generated an isogenic inducible-HORMAD1 expressing cell line model using the copy number stable, …
-
Investigating immune responses in HORMAD1-positive tumours
… genomic instability measures, aneuploidy and homologous recombination deficiency (HRD) related genomic instabilities are higher amongst <i>HORMAD1</i>-positive primary tumours of breast, lung, and stomach cancers. In contrast, <i>HORMAD1</i>-positive ovarian cancers display decreased levels of …
-
Μελέτη του γενωμικού υπόβαθρου και της επίδρασης της νέο-επικουρικής θεραπείας σε ασθενείς με επιθηλιακό καρκίνο των ωοθηκών
… (FFPE) tumor pre- and post-NACT tissues. Homologous recombination deficiency (HRD), tumor infiltrating lymphocytes (TIL), tumor molecular alterations and tumor mutational burden (TMB) via next-generation sequencing analysis were assessed. Results: Overall, tumors from thirty-six patients …
-
Applying genomic biomarkers to understand tumour biology and optimise therapy in paediatric cancers
… of harbouring germline mismatch repair deficiency with high sensitivity and high specificity. For Aim 2, I interrogated the utility of biomarkers of homologous recombination deficiency as a matter of urgency as these are currently being applied to predict PARP inhibitor sensitivity in …
-
Characterization of cellular interactions in histopathology images for clinical and biomedical research using deep learning models
… (i.e., patient with positive or negative homologous recombination deficiency status) into different cohorts with distinct prognostic trajectories. Furthermore, in an exploratory study, the proposed method demonstrates the capability to predict high-grade serous ovarian cancer response to …
-
High-resolution copy-number mutational signatures for ovarian cancer patient stratification
… cohort into two patient subgroups, those with homologous recombination deficiency (HRD) and chromoplexy (whereby chains of translocations and deletions occur across multiple chromosomes), and those with variation caused by chromosome segregation errors. However, a survival analysis suggested no …
Page 1 of 2